Get started
Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 ShsEli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 ShsEli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs

Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsSeasonalsBonds

LLYD chart


Full chart

Key facts today


Eli Lilly's orforglipron is expected to generate $12 billion in sales by 2032, far exceeding Novo's oral semaglutide, projected at $3.5 billion, highlighting market competition.
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪711.73 B‬ USD
Dividend yield (indicated)
0.48%
Price to earnings Ratio (TTM)
70.60
Basic EPS (TTM)
0.25 USD
Net income (FY)
‪9.41 B‬ USD
Revenue (FY)
‪40.01 B‬ USD
Shares float
—
Beta (1Y)
−0.08

About Eli Lilly and Company


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
David A. Ricks
Website
lilly.com
Headquarters
Indianapolis
Founded
1876
ISIN
ARDEUT111192
FIGI
BBG000HFVYP1
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Check out other big names from the same industry as LLYD.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

LLYD news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

LLYD highest yielding bonds


XS238628644
Eli Lilly and Company 1.625% 14-SEP-2043
Yield to maturity
5.91%
Maturity date
Sep 14, 2043
LLY4099975
Eli Lilly and Company 4.65% 15-JUN-2044
Yield to maturity
5.65%
Maturity date
Jun 15, 2044
LLY6153503
Eli Lilly and Company 5.65% 15-OCT-2065
Yield to maturity
5.44%
Maturity date
Oct 15, 2065
LLY6003397
Eli Lilly and Company 5.6% 12-FEB-2065
Yield to maturity
5.43%
Maturity date
Feb 12, 2065
LLY5750032
Eli Lilly and Company 5.1% 09-FEB-2064
Yield to maturity
5.43%
Maturity date
Feb 9, 2064
LLY5871804
Eli Lilly and Company 5.2% 14-AUG-2064
Yield to maturity
5.43%
Maturity date
Aug 14, 2064
US532457BU1
Eli Lilly and Company 4.15% 15-MAR-2059
Yield to maturity
5.41%
Maturity date
Mar 15, 2059
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063
Yield to maturity
5.40%
Maturity date
Feb 27, 2063
US532457BY3
Eli Lilly and Company 2.25% 15-MAY-2050
Yield to maturity
5.38%
Maturity date
May 15, 2050
LLY6153502
Eli Lilly and Company 5.55% 15-OCT-2055
Yield to maturity
5.35%
Maturity date
Oct 15, 2055
LLY6003396
Eli Lilly and Company 5.5% 12-FEB-2055
Yield to maturity
5.34%
Maturity date
Feb 12, 2055

See all LLYD bonds 

Sparks


Curated watchlists where LLYD is featured.

See all sparks